Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.37), $0.12 worse than the analyst estimate of ($0.25).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.